1540 related articles for article (PubMed ID: 7587918)
1. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri M; Kishikawa H; Ohkubo Y; Wake N
Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.
Wake N; Hisashige A; Katayama T; Kishikawa H; Ohkubo Y; Sakai M; Araki E; Shichiri M
Diabetes Res Clin Pract; 2000 Jun; 48(3):201-10. PubMed ID: 10802159
[TBL] [Abstract][Full Text] [Related]
4. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
5. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
Schrier RW; Estacio RO; Esler A; Mehler P
Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
[TBL] [Abstract][Full Text] [Related]
6. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
[TBL] [Abstract][Full Text] [Related]
8. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
9. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
[TBL] [Abstract][Full Text] [Related]
10. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
Hanssen KF; Bangstad HJ; Brinchmann-Hansen O; Dahl-Jørgensen K
Diabet Med; 1992 Oct; 9(8):697-705. PubMed ID: 1395460
[No Abstract] [Full Text] [Related]
11. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
14. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects.
Nakano S; Fukuda M; Hotta F; Ito T; Ishii T; Kitazawa M; Nishizawa M; Kigoshi T; Uchida K
Diabetes; 1998 Sep; 47(9):1501-6. PubMed ID: 9726241
[TBL] [Abstract][Full Text] [Related]
15. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
16. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
Nordwall M; Hyllienmark L; Ludvigsson J
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
[TBL] [Abstract][Full Text] [Related]
17. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
[TBL] [Abstract][Full Text] [Related]
18. Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study.
Cathelineau G; de Champvallins M; Bouallouche A; Lesobre B
Metabolism; 1997 Dec; 46(12 Suppl 1):31-4. PubMed ID: 9439556
[TBL] [Abstract][Full Text] [Related]
19. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
Schrier RW; Estacio RO; Jeffers B
Diabetologia; 1996 Dec; 39(12):1646-54. PubMed ID: 8960857
[TBL] [Abstract][Full Text] [Related]
20. Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes.
Fried LF; Forrest KY; Ellis D; Chang Y; Silvers N; Orchard TJ
J Diabetes Complications; 2001; 15(3):113-9. PubMed ID: 11358679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]